Key result
Patients with ME/CFS had significantly increased plasma levels of endothelial dysfunction-related microRNAs (miR-21, miR-34a, miR-92a, miR-126, and miR-200c) compared to healthy controls.
Why the study?
Endothelial dysfunction has emerged as a player in ME/CFS pathogenesis, but no study had addressed the Sirt1/eNOS axis in this population.
Are endothelial dysfunction-related microRNAs altered in the plasma of patients with ME/CFS compared to healthy controls?
Case-Control (n=87)
No
Are endothelial dysfunction-related microRNAs altered in the plasma of patients with ME/CFS compared to healthy controls?
Endothelial dysfunction-related microRNAs are significantly elevated in the plasma of ME/CFS patients, suggesting a potential role for vascular alterations in the disease's pathogenesis.
Endothelial dysfunction may contribute to ME/CFS; leaves open therapeutic targeting pending confirmation.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease characterized by unexplained debilitating fatigue. Although the etiology is unknown, evidence supports immunological abnormalities, such as persistent inflammation and immune-cell activation, in a subset of patients. Since the interplay between inflammation and vascular alterations is well-established in other diseases, endothelial dysfunction has emerged as another player in ME/CFS pathogenesis. Endothelial nitric oxide synthase (eNOS) generates nitric oxide (NO) that maintains endothelial homeostasis. eNOS is activated by silent information regulator 1 (Sirt1), an anti-inflammatory protein. Despite its relevance, no study has addressed the Sirt1/eNOS axis in ME/CFS. The interest in circulating microRNAs (miRs) as potential biomarkers in ME/CFS has increased in recent years. Accordingly, we analyze a set of miRs reported to modulate the Sirt1/eNOS axis using plasma from ME/CFS patients. Our results show that miR-21, miR-34a, miR-92a, miR-126, and miR-200c are jointly increased in ME/CFS patients compared to healthy controls. A similar finding was obtained when analyzing public miR data on peripheral blood mononuclear cells. Bioinformatics analysis shows that endothelial function-related signaling pathways are associated with these miRs, including oxidative stress and oxygen regulation. Interestingly, histone deacetylase 1, a protein responsible for epigenetic regulations, represented the most relevant node within the network. In conclusion, our study provides a basis to find endothelial dysfunction-related biomarkers and explore novel targets in ME/CFS.
No takes yet. Share an insight, caveat, or question.
Blauensteiner et al. (2021) conducted a case-control in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (n=87). Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) vs. Healthy controls was evaluated on Plasma expression levels of endothelial dysfunction-related microRNAs (miR-21, miR-34a, miR-92a, miR-126, and miR-200c). Patients with ME/CFS had significantly increased plasma levels of endothelial dysfunction-related microRNAs (miR-21, miR-34a, miR-92a, miR-126, and miR-200c) compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: